These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 31561937)

  • 21. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.
    Codd R; Braich N; Liu J; Soe CZ; Pakchung AA
    Int J Biochem Cell Biol; 2009 Apr; 41(4):736-9. PubMed ID: 18725319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescent molecular probe-based activity and inhibition monitoring of histone deacetylases.
    Roopa ; Priya B; Bhalla V; Kumar M; Kumar N
    Chem Commun (Camb); 2021 Oct; 57(85):11153-11164. PubMed ID: 34613324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
    Kee HJ; Kook H
    J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human neuronal cells: epigenetic aspects.
    Kukucka J; Wyllie T; Read J; Mahoney L; Suphioglu C
    Biomol Concepts; 2013 Aug; 4(4):319-33. PubMed ID: 25436583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Histone Acetyltransferases and Histone Deacetylases in Photoreceptor Differentiation and Degeneration.
    Zhao M; Tao Y; Peng GH
    Int J Med Sci; 2020; 17(10):1307-1314. PubMed ID: 32624685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of histone deacetylases in embryonic development.
    Dsilva P; Pai P; Shetty MG; Babitha KS
    Mol Reprod Dev; 2023 Jan; 90(1):14-26. PubMed ID: 36534913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity.
    Godoy LD; Lucas JE; Bender AJ; Romanick SS; Ferguson BS
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27981795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements.
    Mielcarek M; Zielonka D; Carnemolla A; Marcinkowski JT; Guidez F
    Front Cell Neurosci; 2015; 9():42. PubMed ID: 25759639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical and structural biology of protein lysine deacetylases.
    Yoshida M; Kudo N; Kosono S; Ito A
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases.
    Sharma S; Sarathlal KC; Taliyan R
    CNS Neurol Disord Drug Targets; 2019; 18(1):11-18. PubMed ID: 30289079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone Acetylation and Plant Development.
    Liu X; Yang S; Yu CW; Chen CY; Wu K
    Enzymes; 2016; 40():173-199. PubMed ID: 27776781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural biology of human metal-dependent histone deacetylases.
    Schapira M
    Handb Exp Pharmacol; 2011; 206():225-40. PubMed ID: 21879452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy.
    Verza FA; Das U; Fachin AL; Dimmock JR; Marins M
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension.
    Kee HJ; Kim I; Jeong MH
    Biochem Pharmacol; 2022 Aug; 202():115111. PubMed ID: 35640713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Sensitive and Flexible Assay for Determining Histone Deacetylase 1 (HDAC1) Activity.
    Wu MY; Wu RC
    Methods Mol Biol; 2016; 1436():3-13. PubMed ID: 27246204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of histone deacetylases in bone development and skeletal disorders.
    Wang JS; Yoon SH; Wein MN
    Bone; 2021 Feb; 143():115606. PubMed ID: 32829038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylases: unique players in shaping the epigenetic histone code.
    Thiagalingam S; Cheng KH; Lee HJ; Mineva N; Thiagalingam A; Ponte JF
    Ann N Y Acad Sci; 2003 Mar; 983():84-100. PubMed ID: 12724214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective.
    Balakin KV; Ivanenkov YA; Kiselyov AS; Tkachenko SE
    Anticancer Agents Med Chem; 2007 Sep; 7(5):576-92. PubMed ID: 17896917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicinal chemistry advances in targeting class I histone deacetylases.
    Abdallah DI; de Araujo ED; Patel NH; Hasan LS; Moriggl R; Krämer OH; Gunning PT
    Explor Target Antitumor Ther; 2023; 4(4):757-779. PubMed ID: 37711592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.